Neonatal Necrotizing Enterocolitis: Clinical Considerations and Pathogenetic Concepts

SAGE Publications - Tập 6 Số 1 - Trang 6-23 - 2003
Wei Hsueh1, Michael S. Caplan2, Xiao Wu Qu1, Xiao Di Tan1, Isabelle G. De Plaen3, Frank González-Crussí1
1Department of Pathology, Children's Memorial Hospital, Northwestern University Medical School, 2300 Children's Plaza, Chicago, IL 60614, USA
2Department of Pediatrics, Evanston Hospital, Northwestern University Medical School, Evanston, IL 60201, USA
3Department of Pediatrics, Children's Memorial Hospital, Northwestern University Medical School, Chicago, IL 60614, USA

Tóm tắt

Necrotizing enterocolitis (NEC), a disease affecting predominantly premature infants, is a leading cause of morbidity and mortality in neonatal intensive care units. Although several predisposing factors have been identified, such as prematurity, enteral feeding, and infection, its pathogenesis remains elusive. In the past 20 years, we have established several animal models of NEC in rats and found several endogenous mediators, especially platelet-activating factor (PAF), which may play a pivotal role in NEC. Injection of PAF induces intestinal necrosis, and PAF antagonists prevent the bowel injury induced by bacterial endotoxin, hypoxia, or challenge with tumor necrosis factor-α (TNF) plus endotoxin in adult rats. The same is true for lesions induced by hypoxia and enteral feeding in neonatal animals. Human patients with NEC show high levels of PAF and decreased plasma PAF-acetylhydrolase, the enzyme degrading PAF. The initial event in our experimental models of NEC is probably polymorphonuclear leukocyte (PMN) activation and adhesion to venules in the intestine, which initiates a local inflammatory reaction involving proinflammatory mediators including TNF, complement, prostaglandins, and leukotriene C4. Subsequent norepinephrine release and mesenteric vasoconstriction result in splanchnic ischemia and reperfusion. Bacterial products (e.g., endotoxin) enter the intestinal tissue during local mucosal barrier breakdown, and endotoxin synergizes with PAF to amplify the inflammation. Reactive oxygen species produced by the activated leukocytes and by intestinal epithelial xanthine oxidase may be the final pathway for tissue injury. Protective mechanisms include nitric oxide produced by the constitutive (mainly neuronal) nitric oxide synthase, and indigenous probiotics such as Bifidobacteria infantis. The former maintains intestinal perfusion and the integrity of the mucosal barrier, and the latter keep virulent bacteria in check. The development of tissue injury depends on the balance between injurious and protective mechanisms.

Từ khóa


Tài liệu tham khảo

10.1016/S0022-3476(05)82418-7

Hack M, 1991, Pediatrics, 87, 587, 10.1542/peds.87.5.587

10.1111/j.1651-2227.1994.tb13236.x

10.1056/NEJM198404263101707

10.1177/014860719902300504

10.1016/0022-3468(94)90147-3

10.1016/S0022-3476(80)80696-2

10.1007/BF00444947

10.1093/oxfordjournals.aje.a112960

10.1016/0022-3468(94)90264-X

10.1111/j.1651-2227.1994.tb13231.x

10.1097/00000658-197801000-00001

10.1016/S0031-3955(16)34975-6

Benirschke K., 1974, Necrotizing Enterocolitis in the Newborn Infant: Report of the 68th Ross Conference on Pediatric Research., 29

deSa DJ, 1976, Perspect Pediatr Pathol, 3, 273

10.1016/S0022-3476(76)80551-3

10.1016/S0022-3476(05)81124-2

10.1016/S0022-3476(05)81125-4

10.1016/0022-3468(69)90186-9

10.1016/S0022-3476(82)80456-3

10.1152/ajplegacy.1971.221.5.1217

Sechi LA, 1993, Am J Physiol, 265, G21

10.1097/00000658-198606000-00002

Crissinger KD, 1981, Am J Physiol, 130, 537

10.1016/S0022-3476(05)81134-5

10.1016/0882-4010(88)90004-6

10.1097/00006454-199408000-00010

10.1016/S0022-3476(79)80675-7

10.1016/S0022-3468(88)80542-6

10.1016/S0022-3476(88)80128-8

10.1001/archpedi.1973.02110190101022

10.1096/fasebj.1.5.3678700

Gonzalez-Crussi F, 1983, The role of platelet-activating factor and endotoxin. Am J Pathol, 112, 127

Hsueh W, 1986, An investigation of secondary mediators in its pathogenesis. Am J Pathol, 122, 231

10.1172/JCI113459

Brown EG, 1980, Neonatal Necrotizing Enterocolitis., 69

10.1146/annurev.pa.27.040187.001505

10.7326/0003-4819-115-6-457

Benveniste J., 1988, Prog Clin Biol Res, 282, 73

10.1146/annurev.bi.55.070186.002411

Handley DA, 1990, Platelet-Activating Factor in Endotoxin and Immune Diseases., 451

Toth PD, 1990, Platelet-Activating Factor in Endotoxin and Immune Diseases., 589

10.1146/annurev.bi.57.070188.002445

Zanetti G, 1992, Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide. J Immunol, 148, 1890

10.1126/science.3764421

10.1038/330662a0

10.1152/ajpcell.1990.259.5.C697

10.1016/0006-291X(89)92689-2

10.1016/0162-3109(82)90019-4

10.1016/0014-2999(86)90690-4

10.1042/bj3220603

10.1046/j.1365-2567.1999.00784.x

Stafforini DM, 1990, J Biol Chem, 265, 9682, 10.1016/S0021-9258(19)38724-1

Tarbet EB, 1991, J Biol Chem, 266, 16667, 10.1016/S0021-9258(18)55353-9

10.1038/374549a0

10.1097/00003246-199108000-00016

Lloberas N, 2002, Prevention by antioxidant treatment. FASEB J, 16, 908

10.1136/gut.44.2.203

Sun X, 1991, J Immunol, 147, 509, 10.4049/jimmunol.147.2.509

Sun XM, 1996, Am J Physiol, 270, G184

Kubes P, 1990, Am J Physiol, 258, G158

Kubes P, 1991, Am J Physiol, 260, G965, 10.1152/ajpcell.1991.260.5.C965

Sun X, 1997, Am J Physiol, 273, G56

Granger DN, 1988, Am J Physiol, 255, H1269

10.1007/BF02899676

10.1136/gut.29.9.1207

Jaattela M., 1991, Lab Invest, 64, 724

Vilcek J, 1991, New insights into the molecular mechanisms of its multiple actions. J Biol Chem, 266, 7313

10.1097/00003246-199310001-00006

10.1084/jem.166.5.1390

Valone FH, 1988, J Immunol, 141, 3945, 10.4049/jimmunol.141.11.3945

Hsueh W, 1990, Immunology, 70, 309

10.1172/JCI114651

Huang L, 1994, Immunology, 83, 65

10.1084/jem.171.1.327

Tan XD, 1993, TNF gene expression in Paneth cells, intestinal eosinophils and macrophages. Am J Pathol, 142, 1858

Nevalainen TJ, 1995, Lab Invest, 72, 201

Tan XD, 1996, J Immunol, 156, 2985, 10.4049/jimmunol.156.8.2985

10.1128/MCB.10.4.1498

Baeuerle PA, 1991, Biochim Bio-phys Acta, 1072, 63

10.1016/0005-2760(94)90105-8

10.1016/S0005-2760(98)00024-1

10.1038/sj.bjp.0703055

Wang H, 2001, FASEB J, 15, A241, 10.1096/fj.00-0310com

De Plaen IG, 2002, Pediatr Res, 51, 139A

10.1038/sj.bjp.0702939

Sun X, 1995, Roles of TNF, complement activation and endogenous PAF production. Dig Dis Sci, 40, 495

10.1016/0016-5085(95)90271-6

10.1172/JCI114164

Siren AL, 1989, Am J Physiol, 257, H25

10.1007/BF01297031

10.1172/JCI112538

Hsueh W, 1988, A mechanistic study of platelet-activating factor-induced bowel necrosis. Gastroenterology, 94, 1412

10.1042/bj3570593

10.1016/S0167-4889(99)00076-2

10.1097/00003246-199902000-00043

10.1203/00006450-199308000-00025

10.1016/S0002-9343(00)00480-0

10.1001/archpedi.1988.02150050070034

10.1016/S0022-3476(88)80580-8

10.1136/bmj.294.6563.13

10.1016/0022-3468(91)90988-6

10.1016/0002-9610(83)90185-X

10.1016/0016-5085(90)90616-9

10.1016/S0031-3955(16)38622-9

10.1016/S0022-3468(86)80228-7

10.1203/00006450-199205000-00002

10.1016/0016-5085(94)90591-6

10.1203/00006450-199308000-00025

10.1056/NEJM199312303292706

10.1016/0022-3468(74)90093-1

10.1016/0022-4804(84)90196-3

10.1097/00005176-199501000-00004

Pitt J, 1977, 1. Role of milk leukocytes. Pediatr Res, 11, 906

Barlow B, 1975, Surgery, 77, 687

10.3109/15513819409037698

10.1097/00005176-199703000-00012

10.1111/j.1476-5381.1993.tb13860.x

10.1203/00006450-199712000-00010

10.1016/0006-2952(94)90216-X

Vadas P, 1993, Circ Shock, 39, 160

10.1016/S0016-5085(99)70450-6

10.1203/00006450-200105000-00007

10.1016/S0022-3476(05)80661-4

10.1067/mpd.2001.110132

10.1159/000243976

Amer MD, 1994, Clin Res, 42, 372A

Farr RS, 1983, Fed Proc, 42, 3120

10.1016/0090-6980(90)90030-Y

10.1016/0140-6736(90)93304-8

10.1203/00006450-199308000-00027

10.1007/s100249900002

Thông tin
Thông tin xuất bản

SAGE Publications

Tập 6 Số 1

6-23

Thông tin tác giả